NUTRIEN LTD. vs Solstice Advanced Materials Inc., two Chemicals stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where NTR and SOLS diverge most: on debt / equity, NTR reads 0.00 and SOLS reads 1.33; on ev/ebitda, NTR reads 5.1 and SOLS reads 58.1. The rest of the comparable metrics sit closer together. What NTR's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | NTR | SOLS |
|---|---|---|
| Price | $65.42 | $61.31 |
| Market cap | $31.8B | $9.8B |
| Sector | Chemicals | Chemicals |
| Stage | Mature | Mature |
| P/E | 14.0 | — |
| P/B | 1.25 | 6.57 |
| P/S | 1.18 | 2.59 |
| EV/EBITDA | 5.1 | 58.1 |
| Revenue growth | +1.6% | +8.7% |
| Gross margin | 31.1% | — |
| Operating margin | 13.9% | — |
| Net margin | 8.5% | 8.9% |
| Return on equity | 9.1% | 22.6% |
| Return on assets | 4.4% | 5.8% |
| Return on invested capital | 11.1% | — |
| FCF yield | 6.7% | 3.5% |
| Debt / equity | 0.00 | 1.33 |
| Current ratio | 1.34 | 1.43 |
| Altman Z (solvency) | 1.87 | 2.21 |
| Piotroski F (quality) | 8 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.